Adverse Effects of Amphotericin B in Patients of Visceral Leishmaniasis: A Short Survey at Research Hospital Patna
Surabhi Bhatnagar1, Shweta1, Krishna Murti2, Ashok Kumar Gupta2 & Santosh Kumar Sudhakar3 Show affiliations
- National Institute of Pharmaceutical Education and Research, India
- National Institute of Education and Research, India
- Rajendra Memorial Research Institute of Medical Sciences, India
Current Research in Virology, Volume 2, Issue 1, pp. 20–24 · doi.org/10.3844/ajvsp.2013.20.24
Abstract
Leishmaniasis is a disease caused by Leishmania parasite. Leishmania currently affects 12 million people in 98 countries, with an annual incidence of approximately two million new cases. Leishmaniasis is a devastating disease impairing economic productivity and impeding socioeconomic development. The objective of this article was to study the adverse effects of amphotericin B in patients of visceral leishmaniasis which was carried out at Rajendra Memorial Research Institute of Medical Sciences (RMRIMS), Patna, India. The numbers of patients included were 19. Subjects of age groups 10-30 years (73.68%) were found to be more susceptible to visceral leishmaniasis. In this short survey we observed that the common adverse effects of amphotericin B among these patients were loss of appetite and nephrotoxicity.
Licence and reuse
Free to read. This article carries the publisher’s copyright, as printed on it: © 2013 Science Publications. It is free to read; ask us before reusing it.
How to reuse this articleResponses (0)
About this article
Bhatnagar, S., Shweta, Murti, K., Gupta, A. K. & Sudhakar, S. K. (2013). Adverse Effects of Amphotericin B in Patients of Visceral Leishmaniasis: A Short Survey at Research Hospital Patna. Current Research in Virology, 2(1), 20–24. https://doi.org/10.3844/ajvsp.2013.20.24
- Licence
- © Science Publications
- Issue
- Volume 2, Issue 1
- Policies
- Editorial independenceUse of generative AIData availabilityAppeals and complaints
- Version
- Version of record